156 related articles for article (PubMed ID: 21539296)
1. A universal method for detection of amyloidogenic misfolded proteins.
Yam AY; Wang X; Gao CM; Connolly MD; Zuckermann RN; Bleu T; Hall J; Fedynyshyn JP; Allauzen S; Peretz D; Salisbury CM
Biochemistry; 2011 May; 50(20):4322-9. PubMed ID: 21539296
[TBL] [Abstract][Full Text] [Related]
2. Disease-associated amyloid and misfolded protein aggregates activate the inflammasome.
Masters SL; O'Neill LA
Trends Mol Med; 2011 May; 17(5):276-82. PubMed ID: 21376667
[TBL] [Abstract][Full Text] [Related]
3. New insights into the mechanisms of protein misfolding and aggregation in amyloidogenic diseases derived from pressure studies.
Foguel D; Silva JL
Biochemistry; 2004 Sep; 43(36):11361-70. PubMed ID: 15350123
[TBL] [Abstract][Full Text] [Related]
4. Protein denaturation and aggregation: Cellular responses to denatured and aggregated proteins.
Meredith SC
Ann N Y Acad Sci; 2005 Dec; 1066():181-221. PubMed ID: 16533927
[TBL] [Abstract][Full Text] [Related]
5. Nanoimaging for protein misfolding diseases.
Lyubchenko YL; Kim BH; Krasnoslobodtsev AV; Yu J
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2010; 2(5):526-43. PubMed ID: 20665728
[TBL] [Abstract][Full Text] [Related]
6. Defective protein folding and aggregation as the basis of neurodegenerative diseases: the darker aspect of proteins.
Naeem A; Fazili NA
Cell Biochem Biophys; 2011 Nov; 61(2):237-50. PubMed ID: 21573992
[TBL] [Abstract][Full Text] [Related]
7. Amyloids, prions and the inherent infectious nature of misfolded protein aggregates.
Soto C; Estrada L; Castilla J
Trends Biochem Sci; 2006 Mar; 31(3):150-5. PubMed ID: 16473510
[TBL] [Abstract][Full Text] [Related]
8. [Amyloidosis: a model of misfolded protein disorder].
Grateau G; Verine J; Delpech M; Ries M
Med Sci (Paris); 2005; 21(6-7):627-33. PubMed ID: 15985206
[TBL] [Abstract][Full Text] [Related]
9. [Immunotherapy targeting misfolded proteins in neurodegenerative disease].
Kanemaru K
Brain Nerve; 2013 Apr; 65(4):469-74. PubMed ID: 23568995
[TBL] [Abstract][Full Text] [Related]
10. Disordered proteins: biological membranes as two-dimensional aggregation matrices.
Byström R; Aisenbrey C; Borowik T; Bokvist M; Lindström F; Sani MA; Olofsson A; Gröbner G
Cell Biochem Biophys; 2008; 52(3):175-89. PubMed ID: 18975139
[TBL] [Abstract][Full Text] [Related]
11. Polyphenolic compounds for treating neurodegenerative disorders involving protein misfolding.
Ho L; Pasinetti GM
Expert Rev Proteomics; 2010 Aug; 7(4):579-89. PubMed ID: 20653511
[TBL] [Abstract][Full Text] [Related]
12. Protein misfolded oligomers: experimental approaches, mechanism of formation, and structure-toxicity relationships.
Bemporad F; Chiti F
Chem Biol; 2012 Mar; 19(3):315-27. PubMed ID: 22444587
[TBL] [Abstract][Full Text] [Related]
13. Protein misfolding and neurodegeneration.
Soto C; Estrada LD
Arch Neurol; 2008 Feb; 65(2):184-9. PubMed ID: 18268186
[TBL] [Abstract][Full Text] [Related]
14. The role of protein misfolding in the pathogenesis of human diseases.
Ellisdon AM; Bottomley SP
IUBMB Life; 2004 Mar; 56(3):119-23. PubMed ID: 15185744
[TBL] [Abstract][Full Text] [Related]
15. Amyloid peptides and proteins in review.
Harrison RS; Sharpe PC; Singh Y; Fairlie DP
Rev Physiol Biochem Pharmacol; 2007; 159():1-77. PubMed ID: 17846922
[TBL] [Abstract][Full Text] [Related]
16. Structure and intermolecular dynamics of aggregates populated during amyloid fibril formation studied by hydrogen/deuterium exchange.
Carulla N; Zhou M; Giralt E; Robinson CV; Dobson CM
Acc Chem Res; 2010 Aug; 43(8):1072-9. PubMed ID: 20557067
[TBL] [Abstract][Full Text] [Related]
17. Amyloid oligomers: spectroscopic characterization of amyloidogenic protein states.
Lindgren M; Hammarström P
FEBS J; 2010 Mar; 277(6):1380-8. PubMed ID: 20148961
[TBL] [Abstract][Full Text] [Related]
18. Protein aggregation diseases: toxicity of soluble prefibrillar aggregates and their clinical significance.
Stefani M
Methods Mol Biol; 2010; 648():25-41. PubMed ID: 20700703
[TBL] [Abstract][Full Text] [Related]
19. Computational analysis of the S. cerevisiae proteome reveals the function and cellular localization of the least and most amyloidogenic proteins.
Tartaglia GG; Caflisch A
Proteins; 2007 Jul; 68(1):273-8. PubMed ID: 17407164
[TBL] [Abstract][Full Text] [Related]
20. (-)-epigallocatechin-3-gallate (EGCG) maintains kappa-casein in its pre-fibrillar state without redirecting its aggregation pathway.
Hudson SA; Ecroyd H; Dehle FC; Musgrave IF; Carver JA
J Mol Biol; 2009 Sep; 392(3):689-700. PubMed ID: 19616561
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
